RTI Surgical Inc (RTIX) was Downgraded by Craig Hallum to ” Hold”. Earlier the firm had a rating of “Buy ” on the company shares. Craig Hallum advised their investors in a research report released on Jul 28, 2016.
On the company’s financial health, RTI Surgical Inc reported $0.03 EPS for the quarter, based on the information available during the earnings call on Apr 28, 2016. Analyst had a consensus estimate of $0.03. The company had revenue of $67.40 million for the quarter, compared to analysts expectations of $65.49 million. The company’s revenue was down -.9 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.05 EPS.
RTI Surgical Inc closed down -0.2 points or -5.83% at $3.23 with 5,15,760 shares getting traded on Thursday. Post opening the session at $3.1, the shares hit an intraday low of $3 and an intraday high of $3.34 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
RTI Surgical Inc. produces orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues and improve surgical outcomes. The Company uses natural tissues metals and synthetics process to produce its products. The Company processes donated human musculoskeletal and other tissue including bone cartilage tendon ligament fascia lata pericardium sclera and dermal tissue and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE TUTOPLAST and CANCELLE SP sterilization processes and manufacture metal and synthetic implants for distribution to hospitals and surgeons. The Company’s business has six categories: spine sports medicine ortho fixation bone graft substitutes and general orthopedic (BGS and general orthopedic) surgical specialties and dental. The Company distributes its implants and services in all 50 states and in over 45 countries worldwide.